pMV306hsp+LuxG13 Citations (34)
Originally described in: Optimisation of bioluminescent reporters for use with mycobacteria.Andreu N, Zelmer A, Fletcher T, Elkington PT, Ward TH, Ripoll J, Parish T, Bancroft GJ, Schaible U, Robertson BD, Wiles S PLoS One. 2010 May 24;5(5):e10777. PubMed Journal
Articles Citing pMV306hsp+LuxG13
| Articles |
|---|
| Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents. Sandhaus S, Annamalai T, Welmaker G, Houghten RA, Paz C, Garcia PK, Andres A, Narula G, Rodrigues Felix C, Geden S, Netherton M, Gupta R, Rohde KH, Giulianotti MA, Tse-Dinh YC. Antimicrob Agents Chemother. 2016 Jun 20;60(7):4028-36. doi: 10.1128/AAC.00288-16. Print 2016 Jul. PubMed |
| Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery. Naran K, Moosa A, Barry CE 3rd, Boshoff HI, Mizrahi V, Warner DF. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6748-6757. doi: 10.1128/AAC.01178-16. Print 2016 Nov. PubMed |
| Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products. Rodrigues Felix C, Gupta R, Geden S, Roberts J, Winder P, Pomponi SA, Diaz MC, Reed JK, Wright AE, Rohde KH. Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00743-17. doi: 10.1128/AAC.00743-17. Print 2017 Aug. PubMed |
| Identification of protective postexposure mycobacterial vaccine antigens using an immunosuppression-based reactivation model in the zebrafish. Myllymaki H, Niskanen M, Luukinen H, Parikka M, Ramet M. Dis Model Mech. 2018 Mar 13;11(3). pii: 11/3/dmm033175. doi: 10.1242/dmm.033175. PubMed |
| Maturing Mycobacterium smegmatis peptidoglycan requires non-canonical crosslinks to maintain shape. Baranowski C, Welsh MA, Sham LT, Eskandarian HA, Lim HC, Kieser KJ, Wagner JC, McKinney JD, Fantner GE, Ioerger TR, Walker S, Bernhardt TG, Rubin EJ, Rego EH. Elife. 2018 Oct 16;7. pii: 37516. doi: 10.7554/eLife.37516. PubMed |
| An explant technique for high-resolution imaging and manipulation of mycobacterial granulomas. Cronan MR, Matty MA, Rosenberg AF, Blanc L, Pyle CJ, Espenschied ST, Rawls JF, Dartois V, Tobin DM. Nat Methods. 2018 Dec;15(12):1098-1107. doi: 10.1038/s41592-018-0215-8. Epub 2018 Nov 30. PubMed |
| Plakinamine P, A Steroidal Alkaloid with Bactericidal Activity against Mycobacterium tuberculosis. Rodrigues Felix C, Roberts JC, Winder PL, Gupta R, Diaz MC, Pomponi SA, Wright AE, Rohde KH. Mar Drugs. 2019 Dec 16;17(12):707. doi: 10.3390/md17120707. PubMed |
| Rifamycin O, An Alternative Anti-Mycobacterium abscessus Agent. Hanh BTB, Park JW, Kim TH, Kim JS, Yang CS, Jang K, Cui J, Oh DC, Jang J. Molecules. 2020 Mar 31;25(7). pii: molecules25071597. doi: 10.3390/molecules25071597. PubMed |
| Illuminating Host-Mycobacterial Interactions with Genome-wide CRISPR Knockout and CRISPRi Screens. Lai Y, Babunovic GH, Cui L, Dedon PC, Doench JG, Fortune SM, Lu TK. Cell Syst. 2020 Sep 23;11(3):239-251.e7. doi: 10.1016/j.cels.2020.08.010. PubMed |
| Antimicrobial photodynamic therapy fighting polymicrobial infections - a journey from in vitro to in vivo. Karner L, Drechsler S, Metzger M, Hacobian A, Schadl B, Slezak P, Grillari J, Dungel P. Photochem Photobiol Sci. 2020 Oct 1;19(10):1332-1343. doi: 10.1039/d0pp00108b. Epub 2020 Sep 30. PubMed |
| Surface-Shaving Proteomics of Mycobacterium marinum Identifies Biofilm Subtype-Specific Changes Affecting Virulence, Tolerance, and Persistence. Savijoki K, Myllymaki H, Luukinen H, Paulamaki L, Vanha-Aho LM, Svorjova A, Miettinen I, Fallarero A, Ihalainen TO, Yli-Kauhaluoma J, Nyman TA, Parikka M. mSystems. 2021 Jun 29;6(3):e0050021. doi: 10.1128/mSystems.00500-21. Epub 2021 Jun 22. PubMed |
| Exploration of Synergistic Action of Cell Wall-Degrading Enzymes against Mycobacterium tuberculosis. van Schie L, Borgers K, Michielsen G, Plets E, Vuylsteke M, Tiels P, Festjens N, Callewaert N. Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0065921. doi: 10.1128/AAC.00659-21. Epub 2021 Jul 19. PubMed |
| Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis. Larkins-Ford J, Greenstein T, Van N, Degefu YN, Olson MC, Sokolov A, Aldridge BB. Cell Syst. 2021 Nov 17;12(11):1046-1063.e7. doi: 10.1016/j.cels.2021.08.004. Epub 2021 Aug 31. PubMed |
| Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against Mycobacterium abscessus. Lee DG, Hwang YH, Park EJ, Kim JH, Ryoo SW. Int J Mol Sci. 2021 Oct 13;22(20). pii: ijms222011029. doi: 10.3390/ijms222011029. PubMed |
| Investigate Natural Product Indolmycin and the Synthetically Improved Analogue Toward Antimycobacterial Agents. Yang Y, Xu Y, Yue Y, Wang H, Cui Y, Pan M, Zhang X, Zhang L, Li H, Xu M, Tang Y, Chen S. ACS Chem Biol. 2022 Jan 21;17(1):39-53. doi: 10.1021/acschembio.1c00394. Epub 2021 Dec 15. PubMed |
| CRISPR Interference Reveals That All-Trans-Retinoic Acid Promotes Macrophage Control of Mycobacterium tuberculosis by Limiting Bacterial Access to Cholesterol and Propionyl Coenzyme A. Babunovic GH, DeJesus MA, Bosch B, Chase MR, Barbier T, Dickey AK, Bryson BD, Rock JM, Fortune SM. mBio. 2022 Jan 18:e0368321. doi: 10.1128/mbio.03683-21. PubMed |
| A selective PPM1A inhibitor activates autophagy to restrict the survival of Mycobacterium tuberculosis. Berton S, Chen L, Liang YC, Xu Z, Afriyie-Asante A, Rajabalee N, Yang W, Sun J. Cell Chem Biol. 2022 Jul 21;29(7):1126-1139.e12. doi: 10.1016/j.chembiol.2022.03.006. Epub 2022 Mar 22. PubMed |
| Synthesis and Evaluation of Marine Natural Product-Inspired Meroterpenoids with Selective Activity toward Dormant Mycobacterium tuberculosis. Si A, Landgraf AD, Geden S, Sucheck SJ, Rohde KH. ACS Omega. 2022 Jun 27;7(27):23487-23496. doi: 10.1021/acsomega.2c01887. eCollection 2022 Jul 12. PubMed |
| TREM2 Promotes Immune Evasion by Mycobacterium tuberculosis in Human Macrophages. Dabla A, Liang YC, Rajabalee N, Irwin C, Moonen CGJ, Willis JV, Berton S, Sun J. mBio. 2022 Aug 30;13(4):e0145622. doi: 10.1128/mbio.01456-22. Epub 2022 Aug 4. PubMed |
| Proton Motive Force-Disrupting Antimycobacterial Guanylurea Polymer. Miranda-Velez M, Sarker GS, Ramisetty P, Geden S, Bartolomeu Halicki PC, Annamalai T, Tse-Dinh YC, Rohde KH, Moon JH. Biomacromolecules. 2022 Nov 14;23(11):4668-4677. doi: 10.1021/acs.biomac.2c00902. Epub 2022 Nov 1. PubMed |
| Potential Use of Mycobacterium paragordonae for Antimycobacterial Drug Screening Systems. Cha GY, Seo H, Oh J, Kim BJ, Kim BJ. J Microbiol. 2023 Jan;61(1):121-129. doi: 10.1007/s12275-022-00009-1. Epub 2023 Jan 31. PubMed |
| Mycobacterium abscessus DosRS two-component system controls a species-specific regulon required for adaptation to hypoxia. Simcox BS, Tomlinson BR, Shaw LN, Rohde KH. Front Cell Infect Microbiol. 2023 Mar 9;13:1144210. doi: 10.3389/fcimb.2023.1144210. eCollection 2023. PubMed |
| Clinically relevant mutations in the PhoR sensor kinase of host-adapted Mycobacterium abscessus isolates impact response to acidic pH and virulence. Belardinelli JM, Arora D, Avanzi C, Wheat WH, Bryant JM, Spencer JS, Blundell TL, Parkhill J, Floto RA, Jackson M. Microbiol Spectr. 2023 Dec 12;11(6):e0158823. doi: 10.1128/spectrum.01588-23. Epub 2023 Oct 24. PubMed |
| Polyphosphate kinase-1 regulates bacterial and host metabolic pathways involved in pathogenesis of Mycobacterium tuberculosis. Chugh S, Tiwari P, Suri C, Gupta SK, Singh P, Bouzeyen R, Kidwai S, Srivastava M, Rameshwaram NR, Kumar Y, Asthana S, Singh R. Proc Natl Acad Sci U S A. 2024 Jan 9;121(2):e2309664121. doi: 10.1073/pnas.2309664121. Epub 2024 Jan 3. PubMed |
| History of tuberculosis disease is associated with genetic regulatory variation in Peruvians. Nieto-Caballero VE, Reijneveld JF, Ruvalcaba A, Innocenzi G, Abeydeera N, Asgari S, Lopez K, Iwany SK, Luo Y, Nathan A, Fernandez-Salinas D, Chinas M, Huang CC, Zhang Z, Leon SR, Calderon RI, Lecca L, Budzik JM, Murray M, Van Rhijn I, Raychaudhuri S, Moody DB, Suliman S, Gutierrez-Arcelus M. PLoS Genet. 2024 Jun 13;20(6):e1011313. doi: 10.1371/journal.pgen.1011313. eCollection 2024 Jun. PubMed |
| Discovery of benzo[c]phenanthridine derivatives with potent activity against multidrug-resistant Mycobacterium tuberculosis. Liang YC, Sun Z, Lu C, Lupien A, Xu Z, Berton S, Xu P, Behr MA, Yang W, Sun J. Microbiol Spectr. 2024 Nov 5;12(11):e0124624. doi: 10.1128/spectrum.01246-24. Epub 2024 Oct 3. PubMed |
| A pH-dependent direct sulfhydrylation pathway is required for the pathogenesis of Mycobacterium tuberculosis. Nain VK, Barik V, Pandey M, Pareek M, Sharma T, Pal R, Tyagi S, Bajpai M, Dwivedi P, Panda BN, Kumar Y, Asthana S, Pandey AK. Commun Biol. 2025 Apr 19;8(1):637. doi: 10.1038/s42003-025-08051-6. PubMed |
| Inter-kingdom signaling by the Legionella autoinducer LAI-1 involves the antimicrobial guanylate binding protein GBP. Solger F, Rauch J, Vormittag S, Fan M, Raykov L, Charki P, Katic A, Letourneur F, Soldati T, Seibel J, Hilbi H. PLoS Pathog. 2025 Apr 29;21(4):e1013026. doi: 10.1371/journal.ppat.1013026. eCollection 2025 Apr. PubMed |
| Synthesis and anti-mycobacterial activity of novel medium-chain beta-lactone derivatives: a multi-target strategy to combat Mycobacterium abscessus. Francis T, Dedaki C, Ananida-Dasenaki P, Bolka D, Albanis K, Foteinakis F, Mezquida J, Hance M, Athanasoulis A, Papagiorgou AK, Karampoula IF, Georgitsis G, Jardin C, Audebert S, Camoin L, Crauste C, Canaan S, Magrioti V, Cavalier JF. RSC Med Chem. 2025 Apr 25;16(7):3251-3272. doi: 10.1039/d5md00102a. eCollection 2025 Jul 16. PubMed |
| VLX600, an anticancer iron chelator, exerts antimicrobial effects on Mycobacterium abscessus infections. Oh J, Choi S, Seo H, Kim DH, Kim H, Lee D, Jang J, Jung S, Lee J-Y, Kim Z, Yim J-J, Kwak N, Kim B-J. Microbiol Spectr. 2025 Aug 5;13(8):e0071925. doi: 10.1128/spectrum.00719-25. Epub 2025 Jun 20. PubMed |
| Phosphoglucomutase A-mediated metabolic adaptation is essential for antibiotic and disease persistence in Mycobacterium tuberculosis. Sharma T, Tyagi S, Pal R, Kundu J, Gupta SK, Barik V, Nain VK, Pandey M, Dwivedi P, Panda BN, Kumar Y, Nanda RK, Chatterjee S, Pandey AK. mSystems. 2025 Jul 22;10(7):e0042025. doi: 10.1128/msystems.00420-25. Epub 2025 Jun 30. PubMed |
| SMURF2 inhibits autophagic control of Mycobacterium tuberculosis in macrophages. Campos PC, Rahlwes KC, Eknitphong VA, Dias BRS, Naqvi KF, Alvarez-Arguedas S, Shiloh MU. bioRxiv [Preprint]. 2025 Sep 5:2025.09.02.673599. doi: 10.1101/2025.09.02.673599. PubMed |
| Mycobacterium tuberculosis triggers reduced inflammatory cytokine responses and virulence in mice lacking Tax1bp1. Chin J, Abeydeera N, Repasy T, Rivera-Lugo R, Mitchell G, Nguyen VQ, Zheng W, Richards A, Stevenson E, Swaney DL, Krogan NJ, Ernst JD, Cox JS, Budzik JM. PLoS Pathog. 2025 Oct 31;21(10):e1012829. doi: 10.1371/journal.ppat.1012829. eCollection 2025 Oct. PubMed |
| Cysteine Reactivity Profiling Identifies Host Regulators of Mycobacterium tuberculosis Replication in Human Macrophages. Neff JK, DeMeester KE, Parraga Solorzano PK, Suciu RM, Dix MM, Simon G, Gianakopoulos MA, Melillo B, Cravatt BF, Shiloh MU. ACS Infect Dis. 2026 Feb 13;12(2):781-793. doi: 10.1021/acsinfecdis.5c00984. Epub 2026 Jan 27. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.